An Interview with Dr. Thomas Madden, Ph.D.
Acuitas Therapeutics President & CEO, Dr. Thomas Madden, was recently interviewed about the work we do, our proprietary lipid nanoparticle delivery system, and how we support partners worldwide in the development of COVID-19 vaccines. It’s a great overview of who
mRNA Vaccines
We’ve been receiving positive feedback on our blog posts. In fact, a teacher friend of one of our team members said that some of our information helped her to map out some course work that focused on vaccines, especially around
mRNA-LNP COVID-19 Vaccines
When asked about the work we do at Acuitas Therapeutics by those who aren’t in our field, it can be a little challenging to explain. We specialize in the development of lipid nanoparticle delivery systems for molecular therapeutics, which sounds